Chiu HI, Su HI, Ko YC, et al. - Researchers conducted the study for determining long-term outcomes and risk factors for failure after mitomycin C (MMC)-augmented initial trabeculectomy (IT) in Taiwanese patients. Between December 2006 and December 2016, medical records of patients with glaucoma undergoing IT were reviewed. Kaplan-Meier survival and Cox proportional analyses assessed success rates and risk factors for failure, respectively. Participants in the study were 190 patients (237 eyes; mean age: 54.0 ± 15.3 years; mean postoperative follow-up period: 68.4 ± 35.1 months). Mean IOP and glaucoma medications reduced from 22.2 ± 10.8 to 14.4 ± 5.2 mmHg and 3.0 ± 0.7 to 1.8 ± 1.2, respectively, at the last visit. Despite adequate long-term success rates, most eyes needed IOP control medication to help the notion of predisposed scarring vitality following MMC-augmented trabeculectomy in patients of Chinese ethnicity.